If you're having trouble viewing this message please visit:
http://www.the-scientist.com/newsletter/etoc/20080701_ireland.html
The Scientist
home subscribe unsubscribe Supplement Date: July 2008  

Welcome to The Scientist's special supplement on the Ireland



Additional support for this supplement was generously provided by our sponsors
Editorial: A new Celtic Culture
By Stephen Pincock and Richard Gallagher

POLICY
SECTION I
Celtic Legends
How Ireland grew from life science irrelevance to global research hub in 50 years.
By Sean Duke
Governmental Vision
A competitive research base will deliver a robust and flexible economy.
By Helena Acheson
Charles Feeney
Famously private, and equally generous, Chuck Feeney helped transform Irish academic research.
By Cormac Sheridan
Coming Home
Decades of emigration left scars on the Irish psyche, but Ireland is reaping the benefits as its Diaspora returns.
By Karlin Lilington
Barry O'Leary
Positioning Ireland as a location for life sciences is a welcome challenge for the head of IDA Ireland.
By Cormac Sheridan
Enterprising Biobusiness
Enterprise Ireland's unique public-private approach to getting research into business.
By Paul Roben
An Underdeveloped Science Culture
The turn to science in Emerald Isle has happened without much public support.
By Brian Trench
Patrick Cunningham
Ireland's chief scientific advisor began as a classics scholar, but was soon won over to animal genetics.
By Cormac Sheridan
INDUSTRY
SECTION II
Bioprocessing Boom-Town
Two new Dublin institutes are helping position Ireland as a world force in bioprocessing.
By Mary Sweetman
The Elan Alumni
Former personnel are spreading the 'Elan testosterone' throughout Irish life sciences.
By Cormac Sheridan
Delivering the Goods
Irish companies provide multinational pharmaceutical companies with a host of services.
By Anna Nolan
Mark Heffernan
This Australian-born, Ireland-based serial entrepreneur is always on the lookout for biotech cherries ripe for the picking.
By Karlin Lillington
Devices Central
How the closure of a computer manufacturing plant gave rise to Galway's thriving medical devices industry.
By Cormac Sheridan
Allen Mcclay
At 80, the founder of Galen and Almac attributes his success to persistance and a special kind of stupidity.
By Karlin Lillington
Big-Time Biotech
Nourished by research funding and optimism, new biotechnology firms are sprouting across the country.
Opsona Therapeutics: Taking a new approach to Toll-like receptors
Merrion Pharmaceuticals: Delivering on expectations
Biotrin A biomakarker stalwart
Celtic Catalysts: A focus on chiral drugs
Alimentary Health: Developing probiotics for clinical use
AGI Therapeutics: Repurposing old drugs for gastrointestinal indications
IdentiGEN: Old bones, new technology
By Cormac Sheridan
A Prescription for Success.
The Pharmaceutical industry is thriving in Ireland.
By Pat Duffy and Matt Corcoran
Reg Shaw
Old-world courtesy helped him rise from untrained bank clerk to the driver of major pharma projects.
By Cormac Sheridan
RESEARCH
SECTION III
Gained in Translation
Bench-to-bedside research is profiting from a collaborative spirit in Northern Ireland and the Republic of Ireland.
By Mary Sweetman
Progress Through Research
Excellent science and researchers are what's needed for Ireland's future High-tech economy.
By Frank Gannon
Fergus Shanahan
The "pharmabiotic" researcher from University College Cork has his mother to thank for his career choice.
By Karlin Lillington
All Together Now
Thanks to the growth in government funding, Irish universities can now cooperate, not just compete.
By Anna Nolan
The Trio from Trinity
Three top immunologists moved back to Ireland in the 1990s and have been attracting great researchers ever since.
By Karlin Lillington
Research in Ireland
Understanding Alzheimer's Disease: Harald Hampel and his team zero in on the disease's biomarkers.
A Matter of Breeding: Emmeline Hill is taking her family's horse-breeding history into the genomic era.
Gut Instincts: Patrick Johnston's team is using transcriptome mapping to help choose treatments for colorectal cancer.
Combination Therapy: Galway's Remedi center brings together stem cells and gene therapy to tissue repair.
Drawn to Death: Apoptosis has fascinated Trinity College Dublin's Seamus Martin since his PhD 20 years ago.
Sweet Spot: Diabetes researchers at the University of Ulster may have hit a winner with a hormone dubbed GIP
By Mary Mulvihill
Brain Strain
Will tight education funding hinder Ireland's efforts to build a knowledge economy?
By Sean Duke


mailing list information

If you want to continue to receive these e-mails, you need do nothing. We welcome new members to our contents alert mailing list and ask you to forward this message to any colleagues who might be interested.

If you no longer wish to receive The Scientist Table of Contents, visit unsubscribe or, alternatively, log in to the My Scientist section of the website and edit your e-mail preferences.

Careers

Visit The Scientist Careers for the latest jobs in the life sciences. Post your resume, get new jobs delivered via e-mail and more. Log on today and take the next step in your career journey.

web program

The Scientist Community

Check out The Scientist Community, the place where professionals from all sides of the life sciences get together to aggregate, share and discuss our experiences. This Community is yours, help shape it!

 ADVERTISEMENT